ArticlePloS one2026
Identification of candidate macrophage-ferroptosis crosstalk genes associated with immune infiltration in myocardial infarction: A bioinformatics analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, myocardial infarction (MI) remains a major cause of morbidity and mortality. Macrophage-mediated inflammation and ferroptosis-related stress responses have both been implicated in MI; however, transcriptomic identification of macrophage- and ferroptosis-related candidate genes requires rigorous control of false-positive findings. In this revised study, two peripheral blood transcriptomic datasets, GSE29532 and GSE48060, were integrated after probe annotation, independent normalization, merging based on common genes, and ComBat batch correction. Batch-correction quality was evaluated using both visualization and quantitative metrics. Differential expression analysis was performed using the limma package with adj.P.Val < 0.05 as the primary threshold. A total of 213 differentially expressed genes were identified, including 101 upregulated and 112 downregulated genes. Intersecting FDR-supported DEGs with macrophage-related and ferroptosis-related gene sets identified seven primary MFRDEGs: SMAD7, MMD, PTPN6, DDIT3, AKR1C3, PHF21A, and ACSL1. GO enrichment analysis was interpreted as exploratory functional annotation because of the small input gene set, whereas whole-ranked-gene GSEA highlighted TNFA/NF-kB inflammatory signaling, complement-related innate immune signaling, and reactive oxygen species-related transcriptional programs. Because the revised PPI analysis did not produce reliable interactions among the seven primary MFRDEGs, candidate gene prioritization was performed instead of defining interaction-derived hub genes. ssGSEA suggested a robust neutrophil-related alteration in MI, while macrophage- and monocyte-related signatures showed trend-level changes after FDR correction. Exploratory ROC analysis was performed for selected candidate genes. RT-qPCR validation further showed that SMAD7, PTPN6, DDIT3, PHF21A, and ACSL1 were increased, whereas MMD and AKR1C3 were decreased in AMI peripheral blood samples, consistent with the transcriptomic results. These findings provide FDR-supported candidate-level evidence linking macrophage- and ferroptosis-related transcriptional alterations to immune signatures in MI and warrant further validation in larger cohorts and mechanistic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.